製品名:4-bromo-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile

IUPAC Name:4-bromo-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile

CAS番号:2068065-05-2
分子式:C8H4BrN3O
純度:95%+
カタログ番号:CM325559
分子量:238.04

包装単位 有効在庫 価格(USD) 数量
CM325559-100mg in stock DzȦ
CM325559-250mg in stock ȦDzȌ
CM325559-1g in stock ȌDzdž

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2068065-05-2
分子式:C8H4BrN3O
融点:-
SMILESコード:N#CC1=C2C(Br)=CC(O)=CN2N=C1
密度:
カタログ番号:CM325559
分子量:238.04
沸点:
MDL番号:
保管方法:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

Column Infos

Selpercatinib
The FDA has granted accelerated approval to selpercatinib (Retevmo; Eli Lilly and Company) for pediatric patients aged 2 years and older with RET-altered metastatic thyroid cancer or solid tumors, the federal agency announced in a press release. Selpercatinib is a highly selective, potent RET inhibitor. It works by blocking a type of enzyme (kinase) and helps prevent the cancer cells from growing.

Related Products